Cibinqo® (abrocitinib)
for Atopic Dermatitis – Eczema

Cibinqo (abrocitinib) is a once-daily oral JAK1 inhibitor used to treat moderate-to-severe eczema (atopic dermatitis) in patients 12 years and older who have not responded to or cannot use topical treatments. By blocking Janus kinase 1 (JAK1), Cibinqo reduces inflammation, helping to relieve itching and improve skin condition.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Atopic Dermatitis - Eczema